Ke-Da Yu Selected Research

NRH - quinone oxidoreductase2

1/2021	Association Between a Tri-allelic Polymorphism in the Estrogen Metabolism Oxidoreductase NRH:Quinone Oxidoreductase 2 Gene and Risk of Breast Cancer by Molecular Subtype.
1/2012	Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation.
12/2009	Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2.
7/2009	Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ke-Da Yu Research Topics

Disease

68	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2007
33	Neoplasms (Cancer) 01/2022 - 02/2011
15	Triple Negative Breast Neoplasms 10/2022 - 05/2013
8	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2011
5	Carcinogenesis 01/2018 - 07/2009
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2015 - 03/2013
2	Carcinoma (Carcinomatosis) 01/2017 - 01/2013
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2015 - 05/2011
2	Obesity 01/2015 - 01/2012
2	Unilateral Breast Neoplasms 01/2014 - 01/2011
2	Residual Neoplasm 12/2013 - 05/2013
2	Macular Degeneration (Age-Related Maculopathy) 01/2012 - 10/2011
1	Premature Menopause 10/2021
1	Infertility (Sterility) 10/2021
1	Cataract (Cataracts) 03/2020
1	Ovarian Epithelial Carcinoma 09/2015
1	Lymphatic Metastasis 09/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2014
1	Hypoxia (Hypoxemia) 06/2014
1	Amenorrhea 04/2014
1	Cardiotoxicity 01/2014
1	Inflammation (Inflammations) 03/2013
1	Infections 03/2013

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 10/2021 - 05/2009
11	Phenobarbital (Luminal)FDA Link 01/2021 - 05/2011
9	Estrogen ReceptorsIBA 01/2022 - 06/2007
9	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 01/2012
8	Messenger RNA (mRNA)IBA 01/2021 - 10/2011
7	human ERBB2 proteinIBA 06/2021 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2011
6	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2012
6	ChemokinesIBA 03/2019 - 02/2011
4	Estrogens (Estrogen)FDA Link 01/2021 - 07/2009
4	NRH - quinone oxidoreductase2IBA 01/2021 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
4	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2012
4	Biological ProductsIBA 01/2019 - 12/2013
4	Toll-Like Receptor 3IBA 01/2019 - 10/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 06/2007
4	ORALIT (ORS)IBA 07/2010 - 06/2010
3	Epirubicin (Ellence)FDA LinkGeneric 10/2021 - 11/2011
3	AnthracyclinesIBA 06/2021 - 05/2012
3	quinone (benzoquinone)IBA 01/2021 - 07/2009
3	Aromatase InhibitorsIBA 03/2020 - 12/2010
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2015
3	Long Noncoding RNAIBA 01/2019 - 01/2016
3	glutathione S-transferase M1IBA 01/2018 - 07/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 11/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 07/2009
2	QuinonesIBA 01/2021 - 07/2009
2	PlatinumIBA 01/2020 - 04/2013
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2018 - 06/2010
2	Phosphotransferases (Kinase)IBA 10/2016 - 05/2014
2	taxaneIBA 01/2016 - 01/2012
2	MicroRNAs (MicroRNA)IBA 04/2013 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 03/2013 - 07/2010
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 12/2010 - 11/2009
2	Tamoxifen FDA LinkGeneric 12/2010 - 06/2007
1	CholesterolIBA 10/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	famitinibIBA 01/2022
1	camrelizumabIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	VaccinesIBA 01/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021
1	CarcinogensIBA 01/2021
1	Pharmaceutical PreparationsIBA 03/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	UbiquitinIBA 01/2019
1	Chemokine ReceptorsIBA 05/2016
1	Androgen Receptors (Androgen Receptor)IBA 03/2016
1	KinesinsIBA 09/2015
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 04/2015
1	Caspase 7IBA 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2014
1	ribosomal protein L39IBA 06/2014
1	Small Interfering RNA (siRNA)IBA 06/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2014
1	Carrier Proteins (Binding Protein)IBA 05/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	Beclin-1IBA 12/2013
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2013
1	Cisplatin (Platino)FDA LinkGeneric 04/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013
1	nedaplatinIBA 04/2013
1	CytokinesIBA 03/2013

Therapy/Procedure

18	Therapeutics 01/2022 - 06/2007
13	Drug Therapy (Chemotherapy) 01/2022 - 05/2009
11	Neoadjuvant Therapy 01/2021 - 01/2012
10	Adjuvant Chemotherapy 10/2021 - 11/2011
3	Radiotherapy 01/2015 - 05/2009
2	Segmental Mastectomy (Lumpectomy) 01/2015 - 01/2011
2	Mastectomy (Mammectomy) 01/2013 - 01/2011
1	Immunotherapy 01/2020
1	Adjuvant Radiotherapy 05/2014
1	Mammaplasty (Breast Reconstruction) 01/2013